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Loss and dispersion of superficial white matter
in Alzheimer’s disease: a diffusion MRI study
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Jonathan M. Schott,1 Hui Zhang,7 Nick C. Fox1,2 and David M. Cash1,2
Pathological cerebral white matter changes in Alzheimer’s disease have been shown using diffusion tensor imaging. Superficial
white matter changes are relatively understudied despite their importance in cortico-cortical connections. Measuring superficial
white matter degeneration using diffusion tensor imaging is challenging due to its complex organizational structure and proximity
to the cortex. To overcome this, we investigated diffusion MRI changes in young-onset Alzheimer’s disease using standard diffu-
sion tensor imaging and Neurite Orientation Dispersion and Density Imaging to distinguish between disease-related changes that
are degenerative (e.g. loss of myelinated fibres) and organizational (e.g. increased fibre dispersion). Twenty-nine young-onset
Alzheimer’s disease patients and 22 healthy controls had both single-shell and multi-shell diffusion MRI. We calculated fractional
anisotropy, mean diffusivity, neurite density index, orientation dispersion index and tissue fraction (1-free water fraction).
Diffusion metrics were sampled in 15 a priori regions of interest at four points along the cortical profile: cortical grey matter, grey/
white boundary, superficial white matter (1 mm below grey/white boundary) and superficial/deeper white matter (2 mm below
grey/white boundary). To estimate cross-sectional group differences, we used average marginal effects from linear mixed effect
models of participants’ diffusion metrics along the cortical profile. The superficial white matter of young-onset Alzheimer’s disease
individuals had lower neurite density index compared to controls in five regions (superior and inferior parietal, precuneus, entorhi-
nal and parahippocampus) (all P<0.05), and higher orientation dispersion index in three regions (fusiform, entorhinal and para-
hippocampus) (all P< 0.05). Young-onset Alzheimer’s disease individuals had lower fractional anisotropy in the entorhinal and
parahippocampus regions (both P< 0.05) and higher fractional anisotropy within the postcentral region (P< 0.05). Mean diffusiv-
ity was higher in the young-onset Alzheimer’s disease group in the parahippocampal region (P< 0.05) and lower in the postcentral,
precentral and superior temporal regions (all P< 0.05). In the overlying grey matter, disease-related changes were largely consistent
with superficial white matter findings when using neurite density index and fractional anisotropy, but appeared at odds with orien-
tation dispersion and mean diffusivity. Tissue fraction was significantly lower across all grey matter regions in young-onset
Alzheimer’s disease individuals (all P< 0.001) but group differences reduced in magnitude and coverage when moving towards the
superficial white matter. These results show that microstructural changes occur within superficial white matter and along the cor-
tical profile in individuals with young-onset Alzheimer’s disease. Lower neurite density and higher orientation dispersion suggests
underlying fibres undergo neurodegeneration and organizational changes, two effects previously indiscernible using standard diffu-
sion tensor metrics in superficial white matter.
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Introduction
Alzheimer’s disease is characterized by progressive neurode-
generative changes that involve both grey matter (GM) and
white matter (WM). Macrostructural GM loss as visualized
in hippocampal atrophy using MRI is characteristic of
Alzheimer’s disease.1,2 However, microstructural change
may appear before macrostructural neurodegeneration and
occur in early stages of the disease.3–5 Disconnection of
neural circuits by means of WM disruption is likely a key
driver for cognitive deficits and may be an important patho-
physiological process of Alzheimer’s disease.6,7
WM is heterogeneous and can be broadly divided into
superficial white matter (SWM) and deep white matter
(DWM).8,9 SWM mainly consists of short, thin, U-fibres
linking nearby gyri that lie up to 2 mm below the cortex
but may represent 57–67% of all WM fibres.10–12 SWM
fibre organization is also highly complex13,14 and may
form sub-networks of its own.15 Unique anatomical, de-
velopmental and cellular SWM properties may lead to
Graphical Abstract
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particular vulnerabilities to Alzheimer’s disease-related
pathology. For example, short, thin fibres prevalent in
SWM are the last WM outside the cortex to myeli-
nate,16,17 which means oligodendrocytes in these regions
may be more vulnerable to metabolic insults.18,19 SWM
contains the highest density of interstitial cells in WM
that harbour neurofibrillary tangles.20,21 Amyloid-b is
also deposited in the SWM of humans and qualitatively
associated with focal SWM demyelination in mice.22,23
Although SWM may be vulnerable to Alzheimer’s dis-
ease pathology and represents the majority of cerebral
WM, relatively few studies have investigated in vivo
SWM changes in Alzheimer’s disease. Magnetization
transfer ratio studies sampled at 3 mm below the GM/
WM boundary found those with Alzheimer’s disease
show demyelination in SWM.24,25 SWM diffusion MRI
(dMRI) studies in Alzheimer’s disease and mild cognitive
impairment have shown increased axial, radial and mean
diffusivity (MD) in temporal, parietal and occipital
regions that are associated with changes in the Mini-
Mental State Examination (MMSE) and with increased
reaction time on a prospective memory task.26–29
SWM’s proximity to cortical GM and its complicated
fibre organization present two major methodological chal-
lenges that hinder the ability of neuroimaging to localize
disease-related changes specific to SWM. First, relatively
large dMRI voxel sizes and varying sampling distances
below the GM/WM boundary make it unclear whether
changes attributed to SWM arise from the cortical GM,
SWM or DWM. Secondly, dMRI signal is often modelled
using a single tensor that may not capture the organiza-
tionally complex microstructure of SWM. Consequently,
Alzheimer’s disease-related SWM changes in commonly
used DTI metrics, such as fractional anisotropy (FA) and
MD, may result from a mixture of WM degeneration and
organizational changes.30 Therefore, current studies show-
ing Alzheimer’s disease-related changes in SWM may be
due to an unknown combination of disease-related effects
and confounding methodological issues.
In order to address some of the challenges with quanti-
fying disease-related changes in SWM, we used Neurite
Orientation Dispersion and Density Imaging (NODDI) to
disentangle neurodegenerative and organizational altera-
tions by independently quantifying the neurite density
index (NDI) and orientation dispersion index (ODI) of
underlying SWM fibres.31 NODDI metrics relate to histo-
logical measures of myelin and tau pathology.32–34
Alzheimer’s disease-related changes in the GM and DWM
have also been observed in those with young-onset
Alzheimer’s disease (YOAD).35,36 The NODDI model
also allows separation of free water fraction (FWF) and
brain tissue, enabling the removal of the confounding
contribution of nearby CSF. We sampled NODDI and
DTI measures at various depths along the cortical profile
(beginning in cortical GM and descending into the SWM)
in 15 a priori cortical regions of interest (ROI) to better
understand effects of Alzheimer’s disease on SWM and
its neighbouring tissue. We hypothesized that we would
replicate significant Alzheimer’s disease-related changes in
SWM using standard DTI metrics, and that significant
Alzheimer’s disease-related SWM changes would remain




Sixty-nine participants were recruited, 45 with YOAD
and 24 healthy controls. The YOAD patients were
recruited from a specialist Cognitive Disorders Clinic be-
tween 2013 and 2015 with probable Alzheimer’s dis-
ease37 and symptom onset <65 years old. Twenty-eight
patients were classified as having typical (amnestic onset)
Alzheimer’s disease and 17 with atypical Alzheimer’s dis-
ease, 14 of whom were diagnosed with posterior cortical
atrophy, 2 with logopenic progressive aphasia and 1 with
atypical frontal Alzheimer’s disease. Twenty-four cogni-
tively healthy controls with similar mean age and sex to
the Alzheimer’s disease cohort were recruited. This cohort
has been described in Slattery et al.36 and Parker et al.35
Each participant underwent MRI and cognitive tests
including MMSE; see Slattery et al.36 for details of cogni-
tive assessments. Ethical approval was obtained from the
National Hospital for Neurology and Neurosurgery
Research Ethics Committee and written informed consent
was obtained from all participants.
Participants were only included in analysis if they had
suitable quality T1-weighted (T1w) , single-shell DTI and
multi-shell NODDI data (see MRI Acquisition, below).
From the original 69 participants, 1 participant was
excluded due to excessive T1w motion, 3 due to image
processing failures of T1w images, 7 due to motion and
processing failures in DTI sequences and 7 due to motion
and processing failures in NODDI sequences. After exclu-
sions, 51 participants remained for analysis (Table 1),
where the YOAD group comprised two clinical





Females/males (n) 12/10 16/13
Age (SD) 60.5 (5.7) 61.7 (4.6)
Age at onset (SD) N/A 56.6 (4.2)
MMSE median (IQR) 30 (1)a* 21 (7)a*




All data are mean (SD) unless stated otherwise. Cortical thickness (mm) is averaged
across a priori ROIs for each participant in each group.
IQR, interquartile range; MMSE, Mini-Mental State Examination; n, number; SD, stand-
ard deviation.
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phenotypes: typical Alzheimer’s disease (n¼ 18) and pos-
terior cortical atrophy (n¼ 11).
MRI acquisition
MR images were acquired on a Siemens Magnetom Trio
(Siemens, Erlangen, Germany) 3 T MRI with a 32-chan-
nel phased array receiver head coil. Structural MRI
sequences included sagittal 3D Magnetization Prepared -
Rapid Gradient Echo (MPRAGE) T1w volumetric MRI
(MPRAGE with TE/TI/TR ¼ 2.9/900/2200 ms, matrix
size 256  256  208, voxel size 1.1 mm isotropic) and
3D T2-weighted (T2w) T2w volumetric MRI (SPACE with
TE/TR ¼ 401/3200 ms, matrix size 256  256  176,
voxel size 1.1 mm isotropic). Diffusion MRI sequences
included a dedicated single-shell acquisition for DTI (spin
echo EPI; 64 diffusion-weighted directions; b¼ 1000 s/
mm2; 9 b¼ 0 s/mm2 images; 96  96  55 slices; voxel
size 2.5 mm isotropic; TR/TE ¼ 6900/91 ms) and a multi-
shell sequence optimized for NODDI (spin echo EPI; 64,
32 and 8 diffusion-weighted directions at b¼ 2000,
b¼ 700 and b¼ 300 s/mm2; 13 interleaved b¼ 0 s/mm2;
96  96  55 slices; voxel size 2.5 mm isotropic; TR/TE
¼ 7000/92 ms). B0 field maps for single-shell and
NODDI sequences were acquired separately to correct for
susceptibility-related distortion in the diffusion images
(TE 1, 2/TR ¼ 4.92, 7.38/688 ms, 64  64  55, voxel
size 3 mm isotropic). DTI and NODDI sequences were
acquired across two scanning sessions (mean scan interval
¼ 8.7 days; SD ¼ 11.2). Participant ages were calculated
at their NODDI scan.
Image processing
Structural images were processed to obtain a high-reso-
lution reconstruction of the cortical surface. The T1w
image was first skull-stripped using a brain mask from
Geodesic Information Flow.38 Cortical surface reconstruc-
tion was then performed on the skull-stripped image
using FreeSurfer 6.0 (https://surfer.nmr.mgh.harvard.edu/)
to segment GM and WM, tessellate the GM/WM bound-
ary and to perform automated topology correction and
surface deformation for optimization of the GM/WM
boundary and GM/CSF boundary.39,40 A volumetric T2w
image was available in all but one participant and
included in the FreeSurfer pipeline in order to improve
detection of the pial surface. After reconstruction, cortical
thickness values were extracted for ROIs based on the
Desikan–Killiany atlas.
Diffusion-weighted image processing involved skull-
stripping with a total intracranial volume mask using
SPM12,41 motion and eddy-current correction using
FSL’s eddy tool42 and susceptibility correction using a
combined approach of phase unwrapping and registra-
tion.43 NiftyFit44 was used to fit a DTI model to the sin-
gle-shell data with a weighted-least squares approach,
and MD and FA maps were extracted from resulting
tensor images. NODDI measures were fitted using
Accelerated Microstructural Imaging via Convex
Optimization,45 which is a linearized formulation of the
NODDI model that tends to improve the speed and sta-
bility of the fit in regions near the cortex.45,46 From the
model, three measures were produced at each voxel:
NDI, ODI and FWF. NDI and ODI quantify the density
and orientation dispersion of neurites in the tissue frac-
tion (TF) of the voxel (where TF ¼ 1FWF). FA, MD,
NDI, ODI and TF maps were used in the analysis of the
cortical profile.
DTI and NODDI maps were registered to the T1w
image with NiftyReg47 using the first b¼ 0 of each se-
quence. The resulting transformations were used to
resample the DTI and NODDI metrics into T1w space
using cubic interpolation. All resampled dMRI images
were visually reviewed to ensure accurate alignment with
the FreeSurfer GM/WM boundary.
Cortical profile extraction
dMRI metrics were sampled along the cortical profile to
allow greater localization of pathological changes in
SWM compared to neighbouring tissues. For each vertex
on the surface representing the GM/WM boundary, DTI
and NODDI metrics were sampled at four distances from
the vertex along the surface normal: 1 mm outwards
(likely GM), 0 mm (GM/WM boundary), 1 mm inwards
(likely SWM), and 2 mm inwards (likely a mixture of
SWM and DWM). We took this approach in order to be
transparent regarding group changes in nearby tissues
that could be the result of partial volume effects arising
from our relatively low spatial resolution.
ROIs measures
For each of the four points sampled along the cortical
profile, summaries of each dMRI metric were obtained
on a ROI level based on anatomical labels from the
FreeSurfer Desikan–Killiany atlas brain parcellation. A
total of 15 a priori ROIs were included in the analysis.
Twelve were chosen from temporal, occipital and parietal
regions that are known to be affected in both clinical
phenotypes within the YOAD group (typical Alzheimer’s
disease and posterior cortical atrophy)48,49: entorhinal,
superior temporal, fusiform, lateral occipital, middle tem-
poral, posterior cingulate, inferior parietal, parahippocam-
pal, cuneus, inferior temporal, precuneus and superior
parietal cortices. Three ROIs in somatosensory cortices,
typically spared until later stages of typical Alzheimer’s
disease and posterior cortical atrophy,48,49 were chosen
to serve as control ROIs: precentral, postcentral and par-
acentral cortices. ROI measures for DTI and NODDI
metrics were averaged across hemispheres. See Fig. 1 for
the full preprocessing pipeline.
While NDI and ODI measures are estimated within the
TF of each voxel, a conventional ROI average would
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equally weight NDI and ODI across the region despite
varying TF likely to occur near the cortex. Therefore, we
used ‘tissue-weighted’ averages of NDI and ODI for all
analyses, where TF at corresponding vertices served as
the weights.
Statistical analysis
All statistical analyses were performed using R 3.6.350
and ROI visualizations were plotted using the ggseg
package.51 Separately, we calculated the average and
standard deviation of observed dMRI metrics across all
15 a priori ROIs in each group. These were plotted to
provide a composite overview of each dMRI metric along
the cortical profile (Fig. 2).
Disease-related changes in dMRI metrics along the cor-
tical profile were modelled using linear mixed effect mod-
els. A total of 75 models were generated (15 a priori
ROIs  5 dMRI metrics). In each model, the outcome
variable was the ROI average of the dMRI metric. The
model included fixed effects for distance, distance-
squared, group (control or YOAD), average cortical
thickness of the ROI, plus interactions between distance
and group, and distance-squared and group terms (see
Supplementary material for equation). Quadratic term for
distance was used to capture non-linear trends observed
when plotting observed data for each ROI (Fig. 2).
Cortical thickness was included in the model as a proxy
for atrophy and we assumed this would be most associ-
ated with diffusion measures in the GM. We therefore set
the GM point as the intercept for the model (dis-
tance¼ 0), with distance increasing in the direction to-
wards the SWM/DWM (distance¼ 4). Age and sex were
not included in the model as they were well balanced in
our cohort and including these as covariates produced no
meaningful change in results across our models. Group-
specific random effects were included for the intercept
and slope, along with a covariance term between the
intercept and slope. In a small number of models (6/75)
where there was difficulty fitting this model, we removed
the random slope for the control group (see
Supplementary material). The average marginal effect
Figure 1 Schematic of preprocessing pipeline to acquire ROI-level metrics at varying levels from the GM/WM boundary.
(A) Structural MRI processing for skull stripping and surface reconstruction to define the GM/WM boundary. (B) dMRI processing to create DTI
maps (MD and FA) and NODDI maps (NDI, ODI and TF). (C) dMRI metrics are sampled at various distances from the GM/WM boundary: GM
(1 mm outwards in green), GM/WM (on the boundary in yellow), SWM (1 mm inwards in red) and SWM/DWM (2 mm inwards in blue). (D) ROI
measures of dMRI metrics, sampled at each distance, are extracted using the Desikan–Killiany atlas from FreeSurfer. ROIs were hypothesized to
either be affected (blue) or not affected (yellow) in the YOAD group.
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(AME) of group, at each of the four distance points, was
estimated using predicted values from the linear mixed ef-
fect models. AMEs represent the estimated difference in
the dMRI metric between the YOAD group compared
with controls, using the observed values of other covari-
ates (here, the cortical thickness). Multiple comparisons
were corrected for using the false discovery rate (FDR)52
across all P-values from our AMEs (15 regions  5 diffu-
sion metrics  4 distances ¼ 300 P-values). Corrected P-
values were considered statistically significant below an
adjusted threshold of 0.05 (pFDR < 0.05). Residuals for
each model were inspected to check model assumptions
were adequately met. We also estimated AMEs across the
GM/WM boundary for NODDI measures when using a
conventional mean rather than tissue-weighted mean
(Supplementary Table 4; Supplementary Figs 5 and 6).
Example R code for fitting linear mixed effect models
and extracting AMEs is included in the Supplementary
material.
Data availability
An anonymized spreadsheet with data used to fit linear
mixed effect models along the cortical profile can be
made available upon reasonable request from researchers.
Results
Figure 2 shows the observed DTI and NODDI metrics
averaged across 15 a priori ROIs along the cortical
Figure 2 Observed dMRI metrics averaged over all a priori ROIs, for each distance across the GM/WM boundary in controls
(black) and YOAD (red) groups. (A) Averaged FA profile shows an increase for both groups when moving into SWM/DWM. (B) Average
MD profile shows an overall decrease when moving into the SWM/DWM. (C) Average NDI profile shows an overall increase when moving into
SWM/DWM. (D) Average ODI profile shows an overall decrease when moving into SWM/DWM. (E) For reference, the average TF profile
shows an overall increase when moving into SWM/DWM. Error bars indicate 6 standard deviation across all 15 ROIs, for each group, at each
distance from GM/WM boundary..
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profile. When using DTI metrics, there was an overall in-
crease in FA when moving from the GM into the SWM/
DWM (Fig. 2A) and an overall decrease in MD
(Fig. 2B) when moving from the GM into the SWM and
DWM. When using NODDI metrics, there was an overall
increase in NDI when moving from the GM into the
SWM/DWM (Fig. 2C) and an overall decrease in ODI
when moving from the GM into the SWM/DWM
(Fig. 2D). There was an overall increase in TF when
moving from GM into SWM/DWM (Fig. 2E).
Group differences, at each of the four distance points
across the GM/WM boundary, were then investigated
for each ROI (Fig. 3A) and each of the five metrics,
using AMEs and their 95% confidence intervals (all
reported results significant at pFDR < 0.05). See
Supplementary Figs 1–3 and Supplementary Tables 1–3
for all AMEs.
Statistically significant findings across the cortical pro-
file using DTI metrics are shown in Fig. 3B and C. In
the SWM (1–2 mm below the GM/WM boundary), those
with YOAD had significantly lower FA compared to con-
trols in the parahippocampal (SWM: AME 0.026, 95%
CI 0.039, 0.013; SWM/DWM: 0.021, 0.037,
0.005) and entorhinal SWM (SWM: 0.031, 95% CI
0.045, 0.016), but higher FA within the postcentral
SWM (SWM/DWM: 0.028, 95% CI 0.010, 0.047). In
the GM and on the GM/WM boundary, YOAD individu-
als had significantly lower FA in six ROIs: parahippo-
campal, entorhinal, inferior and superior parietal, lateral
occipital cortices and the cuneus (Fig. 3B).
The YOAD group showed significantly higher MD
compared to controls in the parahippocampal SWM
(SWM: 0.038, 95% CI 0.009–0.067), but significantly
lower MD in the SWM of pre- and postcentral gyri, and
Figure 3 Regional group differences along the cortical profile. (A) A priori ROIs were chosen due to prior knowledge of affected
areas in YOAD (blue) or as control ROIs (yellow). Diffusion metrics were obtained along the cortical profile. (B–F) DTI, NODDI and TF
AMEs (pFDR < 0.05) representing the difference in dMRI metric between controls and YOAD, in each ROI, at each distance across the GM/
WM boundary from the linear mixed effect models [GM (1 mm outward from GM/WM boundary), GM/WM boundary, SWM (1 mm inwards
from GM/WM boundary), SWM/DWM (2 mm inwards from GM/WM boundary)]. Negative AMEs (purple/blue colourmap) indicate a lower
dMRI metric in the YOAD group, while positive AMEs (red/cream colourmap) indicate a higher metric in the YOAD group. A priori ROIs not
coloured in plots have pFDR > 0.05. Supplementary Fig. 4 shows AMEs at uncorrected P< 0.05.
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the superior temporal region. This contrasts with YOAD
individuals having significantly higher MD across all
ROIs in the GM and in all but two ROIs in on the GM/
WM boundary (Fig. 3C).
Statistically significant findings across the cortical pro-
file using NODDI metrics are shown in Fig. 3D and E.
In the SWM (1–2 mm below the GM/WM boundary),
individuals with YOAD had significantly lower NDI in
the inferior and superior parietal, precuneus, parahippo-
campal and entorhinal regions (Fig. 3D). In parietal
regions, lower NDI in those with YOAD was consistent
with lower NDI the overlying GM and on the GM/WM
boundary, but no significant group differences were
observed within entorhinal, parahippocampal and precu-
neus GM.
YOAD individuals had significantly higher ODI com-
pared to controls in the SWM of the parahippocampal
(SWM: 0.020, 95% CI 0.010–0.030; SWM/DWM:
0.016, 95% CI 0.003–0.030), entorhinal (SWM: 0.033,
95% CI 0.019–0.048) and fusiform ROIs (SWM: 0.017,
95% CI 0.004–0.030). This largely contrasted with find-
ings in the GM, where those with YOAD had significant-
ly lower ODI in widespread regions of GM, such as
parahippocampal, superior and inferior parietal, middle
temporal and posterior cingulate ROIs. On the GM/WM
boundary, those with YOAD also had lower ODI com-
pared to controls in the superior parietal lobe (GM/WM:
0.022, 95% CI 0.035, 0.008) but significantly
higher ODI in the entorhinal ROI (GM/WM: 0.029,
95% CI 0.016–0.042) (Fig. 3E).
We report statistically significant group differences for
TF along the cortical profile to provide a reference for
DTI and NODDI metric results with respect to macro-
scopic diffusion changes (Fig. 3F). TF in GM and on the
GM/WM boundary was significantly lower in YOAD
compared to controls across all a priori ROIs. TF in
SWM remained significantly lower in YOAD compared
to controls, but in fewer ROIs and at a reduced magni-
tude. TF in SWM/DWM was significantly lower in
YOAD compared to controls in only three ROIs but
higher within the superior temporal ROI (SWM/DWM:
0.016, 95% CI 0.005–0.026) (Fig. 3F).
Discussion
In this study we show that (i) NODDI detects disease-
related microstructural changes in the SWM of those
with YOAD; (ii) these Alzheimer’s disease-related SWM
changes do not wholly overlap with DTI metrics; and
(iii) these microstructural changes vary in their relation-
ship to overlying GM. To our knowledge, this work is
both the first to investigate Alzheimer’s disease-related
SWM changes using NODDI and to contextualize these
findings within the cortical profile of individuals with
Alzheimer’s disease.
Our main findings indicate that individuals with
YOAD have reduced NDI in the SWM of parietal, para-
hippocampal, entorhinal and precuneus SWM but
increased ODI in the parahippocampal, entorhinal and
fusiform SWM. These effects appear to overlap in some
regions (e.g. parahippocampal SWM). However, other
regions may only detect either a loss of fibres indicated
by decreased NDI (e.g. precuneus SWM) (Fig. 3D), or
greater fibre dispersion indicated by increase ODI (e.g.
fusiform SWM) (Fig. 3E). This suggests that myelinated
fibres in the SWM undergo both neurodegeneration and
organizational changes in YOAD but that these changes
may not always co-localize.
NODDI SWM findings overlap with conventional DTI
metrics in regions typically affected early in the disease
such as the parahippocampus and entorhinal regions.53,54
For example, those with YOAD had lower NDI and FA,
but higher MD and ODI, in parahippocampal SWM com-
pared to controls (Fig. 3B–E). A simultaneous reduction
in NDI and increase in ODI here implies FA and MD
changes are being driven by both degeneration and disper-
sion of WM fibres. These concomitant decreases in FA
and NDI with increases in ODI have also been observed
in the WM of transgenic mice models of tauopathy that
are linked to WM disorganization.32,55 Moreover, intersti-
tial cells prevalent in SWM are susceptible to cytoskeletal
changes in the entorhinal region and may contribute to
these disease-related SWM changes.20
In other regions, NODDI and DTI findings in SWM
were not always congruent. Only NDI showed
Alzheimer’s disease-related SWM changes in the parietal
and precuneus regions, which likely reflects loss of under-
lying myelinated fibres but may not result in a detectable
change of FA,31,33 potentially due to complex crossing
fibres in the underlying SWM.13–15 A significant increase
in ODI alone (e.g. fusiform SWM) indicates increased
fibre dispersion in the YOAD group being the dominat-
ing microstructural change, with no statistically signifi-
cant loss of underlying myelinated fibres. Myelinated
fibre disorganization has also been observed at post-mor-
tem in the cortex of YOAD individuals56 but it is un-
known if this extends into SWM.
Conversely, only DTI metrics indicated significant
group changes in the superior temporal and central sul-
cus regions (Fig. 3B and C). Higher FA and lower MD
in YOAD individuals’ SWM is less clear, but one ex-
planation could be compensatory mechanisms, particu-
larly in regions typically affected by atrophy in later
stages such as two of our control regions within the
central sulcus. For example, previous FA increases have
been observed in asymptomatic amyloid positive individ-
uals57 and transgenic mouse models of Alzheimer’s dis-
ease prior to intraneuronal plaque accumulation.58 It
has been suggested that early amyloid deposition may
create an inflammatory response, initiating widespread
proliferation of microglia that increase the density of
cell membrane barriers in a voxel, and thus increase
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restricted diffusivity and FA in white matter.59,60
Alternatively, previous work has attributed increased an-
isotropy to a degeneration of crossing fibres and sparing
of motor-related projection fibres.61 However, with no
corresponding NDI or ODI changes in these regions
that met our FDR-corrected threshold for multiple com-
parisons, the specific microstructural changes driving
DTI here are unclear.
Our results do not replicate previous DTI-based find-
ings in the SWM of those with Alzheimer’s disease.
Previous studies of Alzheimer’s disease-related changes in
SWM found widespread increases in MD,26,28,29 where
our results suggest higher MD in those with Alzheimer’s
disease only within the parahippocampal SWM. We also
report reduced MD in those with Alzheimer’s disease in
the SWM of the central sulcus and superior temporal
regions. This could be due to the inclusion of cortical
thickness as a covariate in our models reducing the influ-
ence of overlying GM atrophy on SWM metrics (see
widespread increased MD in those with Alzheimer’s dis-
ease stopping on the GM/WM boundary in Fig. 3C).
Taking the NODDI and DTI SWM findings together,
NODDI metrics in SWM can detect distinct Alzheimer’s
disease-related changes, but together with DTI depict a
complex microstructural environment that is likely under-
going spatially heterogeneous pathophysiological effects
of Alzheimer’s disease. Further investigation into
Alzheimer’s disease-related SWM changes is needed to de-
termine the source of these microstructural effects.
Diffusion metrics also varied when moving along the
cortical profile for all participants (Fig. 2). FA increased
and MD decreased when moving from GM into SWM,
which suggests diffusion in the SWM and DWM is more
restricted and anisotropic than in the GM. Kang et al.62
also showed increasing FA and decreasing MD in healthy
controls and suggested MD values were significantly
affected by partial voluming of CSF. Cortical atrophy in
the YOAD group would increase the likelihood of CSF
contamination within voxels classified as GM, making it
difficult to determine whether changes are entirely due to
intrinsic tissue properties from FA and MD alone.
Conversely, NODDI metrics allow for the modelling of
this partial volume effect with the free water compart-
ment.31 While explicitly taking free water into account on
the regional level using tissue-weighted averages, NDI
increased and ODI decreased when moving from GM into
the SWM which provides evidence that changes in FA and
MD are partially due to histological features of increased
myelination and parallel fibre organization in WM.
When viewing group effects with NODDI along the cor-
tical profile, YOAD individuals showed a sustained reduc-
tion in NDI within parietal regions compared to controls,
which may indicate reduced density of myelinated neurites
in both GM and SWM.33 YOAD individuals showed
decreased ODI within GM but increased ODI within cer-
tain SWM regions compared to controls. Although most
prominent in the parahippocampus, there is a trend of
higher ODI in YOAD individuals across more SWM
regions when uncorrected for multiple comparisons
(Supplementary Fig. 4). A potential flattening of ODI
along the cortical profile suggests neurite organization
could become more similar across the GM/WM boundary
in YOAD and may be associated with blurring of the
GM/WM boundary observed in T1w sequences.
63–65
dMRI measures in GM and SWM are likely affected
by confounding effects of nearby CSF which is further
implicated by GM atrophy in our YOAD group. We
decided to account for CSF partial volume effects using
(i) cortical thickness measures within the models for all
dMRI metrics and (ii) calculating NODDI metrics as tis-
sue weighted averages where TF acted as the weights
(where TF ¼ 1FWF). We also analysed TF changes in
order to determine whether macrostructural diffusion
changes, likely attributed to the influence of nearby free
water in CSF, are occuring simultaneously in these
regions across the cortical profile (Fig. 3F). The YOAD
group had lower TF across all GM regions with smaller
but significant group differences remaining in the SWM
of fewer regions. This suggests that disease-related
changes in diffusion tensor metrics in the GM and on the
GM/WM boundary are likely to be strongly influenced
by free water and partial volume effects. Indeed, striking
similarities between MD and TF measures can be
observed in the cortical profiles and group differences
(Figs 2B, E, 3C and F). Exploratory scatterplots of MD
versus TF indicate a prominent negative relationship in
the GM and on the GM/WM boundary across all a pri-
ori ROIs, but diminishes when entering SWM
(Supplementary Fig. 7). Therefore, MD findings in the
GM and GM/WM boundary may be driven by FWF in
the nearby CSF. This suggests previous Alzheimer’s dis-
ease-related SWM changes sampled on the GM/WM
boundary may be influenced by partial volume effects
and supports findings of CSF confounding DTI measures
in Alzheimer’s disease that can artificially inflate MD.66
Owing to SWM’s proximity to the overlying cortical
GM, we recommend the use of dMRI models that take
free water into account, such as NODDI or free-water
elimination DTI,67,68 to allow for more specific insights
into pathological microstructural changes.
Nevertheless, when taking TF into account using tissue-
weighted averages, NDI and ODI still showed disease-
related changes in the GM. This complements previous
NODDI work in GM of Alzheimer’s disease partici-
pants35,69 by showing Alzheimer’s disease-related reduc-
tions in NDI and ODI remain, even when explicitly
accounting for the varying degree of FWF within regions.
We also provide NODDI results with conventional region-
al averages as a reference point to previous GM work
(Supplementary Figs 5 and 6; Supplementary Table 4).
Future studies could further overcome CSF and atrophy
confounds by studying microstructural GM and SWM
changes in individuals at-risk of developing Alzheimer’s
disease before macrostructural neurodegeneration occurs.
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Varying regional differences in NODDI and DTI met-
rics may also be due to the spatial distribution of under-
lying pathology of clinical phenotypes in our YOAD
cohort (typical Alzheimer’s disease and posterior cortical
atrophy) in addition to varying SWM properties across
regions. Atrophy patterns do not completely overlap be-
tween typical Alzheimer’s disease (temporo-parietal atro-
phy) and posterior cortical atrophy (occipito-parietal
atrophy),49,70 while the ability to detect reproducible
in vivo SWM fibres using dMRI varies across regions
and techniques.9 This spatial heterogeneity in both path-
ology and dMRI’s sensitivity to underlying SWM may
obscure our ability to detect underlying microstructural
changes. Although previous dMRI studies have shown
phenotypic differences within WM and cortical GM,71,72
the low number of participants within each clinical
phenotype of our cohort (18 with typical Alzheimer’s dis-
ease and 11 with posterior cortical atrophy) means we
lack sufficient data to reliably estimate differences be-
tween phenotypes using our linear mixed effect model ap-
proach. Future studies with a larger sample size could
determine whether SWM changes vary between forms of
YOAD. Other potential sources of changes in SWM in-
clude vascular damage. We did not distinguish between
SWM changes that may arise from either normal appear-
ing white matter or white matter hyperintensities.
However, an advantage of studying YOAD individuals is
that vascular comorbidities are less likely than in those
who develop symptoms later in life. Indeed, all partici-
pants in our cohort scored 4 or lower on the Hachinski
Ischaemic score.36 More work is needed to distinguish
the contributing factors of in vivo SWM measures.
A limitation of this work is the potential influence of
partial volume effects due to the spatial resolution of our
dataset (2.5 mm isotropic). We opted for a ‘WM mesh’
approach9 to determine Alzheimer’s disease-related
changes within the SWM region as opposed to extracting
specific U-fibre tracts. In addition, we sampled at four
points across the GM/WM boundary and modelled the
relationship between these points to mitigate misinterpeta-
tions of SWM changes. Despite these efforts some influ-
ence from partial volume effects will occur and
microstructural SWM properties extracted at our spatial
resolution could reduce the ability to definitively detect
signal attributed to the SWM. While U-fibres have been
extracted at 1.25 mm and 2 mm isotropic dMRI resolu-
tions,9,73 submillimetre diffusion MRI greatly improves
detection of U-fibres.74 Indeed, recent advances in submil-
limetre dMRI enable highly reproducible in vivo U-fibre
tracts75 and the ability to delineate SWM from nearby
GM and DWM using iron levels in high-resolution quan-
titative MRI.12 This highlights the importance of high-
resolution techniques for studying SWM in vivo and eval-
uating its trade-off with scan duration to determine the
clinical applications of SWM-based biomarkers.
Another potential limitation is the role of cortical topog-
raphy. Curvature of the cortex is known to influence
dMRI measures, thus averaging dMRI metrics in an ROI
across gyri and sulci could blur and mask true changes.
Curvature also varies across brain regions throughout the
lifespan and sulcal widening is a prominent feature of
macrostructural Alzheimer’s disease changes, which may
further contribute to heterogeneous SWM dMRI met-
rics.76–78 This could be investigated by segmenting ROIs
into curvature-based subregions to determine if SWM
measures vary in gyri versus sulci.79 Head motion’s influ-
ence on dMRI metrics is also well known. Owing to the
number of parameters in our linear mixed effect models,
we did not include motion parameters as nuisance regres-
sors. To reduce the influence of motion, we removed indi-
viduals with excessive head motion using quality control
procedures that included visual inspection, normalized
cross-correlation plots and translation-rotation plots.80
Moreover, SWM extraction using FreeSurfer is suboptimal
as projecting along the surface normal from the GM/WM
boundary can produce unrealistic SWM sampling. A re-
cently developed gyral coordinate system that interpolates
underlying fibre orientations from gyral morphology has
shown to align with primary DTI eigenvectors, and may
provide a novel way to investigate in vivo SWM changes
in Alzheimer’s disease.81 Finally, this work focussed on
dMRI models’ ability to detect disease-related SWM
changes but we did not investigate their association with
cognitive measures. Determining the clinical significance of
microstructural SWM changes, potentially by predicting fu-
ture cognitive decline, will be an important step for under-
standing SWM’s role in Alzheimer’s disease.
In conclusion, we show that Alzheimer’s disease-related
microstructural changes occur within SWM and along the
cortical profile. We independently quantified the density
and dispersion of underlying SWM neurites using NODDI,
two metrics that cannot be disentangled using standard
tensor metrics used in previous dMRI studies of SWM in
Alzheimer’s disease. For the first time, we show lower
NDI and higher ODI in the SWM of those with YOAD,
likely due to a simultaneous loss, but greater dispersion, of
myelinated fibres. Complex fibres linking nearby gyri in
SWM may represent an overlooked region of WM
changes in Alzheimer’s disease that could help maximize
the usefulness of WM as a neuroimaging biomarker.
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